135 related articles for article (PubMed ID: 16720921)
1. The value of serum bcl-2 levels in advanced epithelial ovarian cancer.
Tas F; Duranyildiz D; Oguz H; Camlica H; Yasasever V; Topuz E
Med Oncol; 2006; 23(2):213-7. PubMed ID: 16720921
[TBL] [Abstract][Full Text] [Related]
2. The value of serum Bcl-2 levels in advanced lung cancer patients.
Tas F; Duranyildiz D; Oguz H; Camlica H; Oral EN; Yasasever V; Topuz E
Med Oncol; 2005; 22(2):139-43. PubMed ID: 15965276
[TBL] [Abstract][Full Text] [Related]
3. Statistical interpretation of CA125 and Bcl-2 in serum of patients with late stage ovarian cancer.
Camlica H; Duranyildiz D; Tas F; Yasasever V
Am J Clin Oncol; 2008 Dec; 31(6):585-8. PubMed ID: 19060592
[TBL] [Abstract][Full Text] [Related]
4. Human kallikrein 6 (hK6): a new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma.
Diamandis EP; Scorilas A; Fracchioli S; Van Gramberen M; De Bruijn H; Henrik A; Soosaipillai A; Grass L; Yousef GM; Stenman UH; Massobrio M; Van Der Zee AG; Vergote I; Katsaros D
J Clin Oncol; 2003 Mar; 21(6):1035-43. PubMed ID: 12637468
[TBL] [Abstract][Full Text] [Related]
5. Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology.
Mok SC; Chao J; Skates S; Wong K; Yiu GK; Muto MG; Berkowitz RS; Cramer DW
J Natl Cancer Inst; 2001 Oct; 93(19):1458-64. PubMed ID: 11584061
[TBL] [Abstract][Full Text] [Related]
6. Serum half-life of CA 125 during early chemotherapy as an independent prognostic variable for patients with advanced epithelial ovarian cancer: results of a multicentric Italian study.
Gadducci A; Zola P; Landoni F; Maggino T; Sartori E; Bergamino T; Cristofani R
Gynecol Oncol; 1995 Jul; 58(1):42-7. PubMed ID: 7789889
[TBL] [Abstract][Full Text] [Related]
7. CA 125 and vascular endothelial growth factor in the differential diagnosis of epithelial ovarian tumors.
Candido Dos Reis F; Moreira de Andrade J; Bighetti S
Gynecol Obstet Invest; 2002; 54(3):132-6. PubMed ID: 12571433
[TBL] [Abstract][Full Text] [Related]
8. Serum CA-125 level after 6 cycles of primary adjuvant chemotherapy is a useful prognostic factor for complete responders' survival in patients with advanced epithelial ovarian cancer.
Kim HS; Park NH; Chung HH; Kim JW; Song YS; Kang SB
Onkologie; 2008 Jun; 31(6):315-20. PubMed ID: 18547972
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of the combined serum CA 125 and TPS during chemotherapy and before second-look laparotomy in epithelial ovarian cancer.
Senapad S; Neungton S; Thirapakawong C; Suphanit I; Hangsubcharoen M; Thamintorn K
Anticancer Res; 2000; 20(2B):1297-300. PubMed ID: 10810438
[TBL] [Abstract][Full Text] [Related]
10. Expression of apoptosis-related proteins is an independent determinant of patient prognosis in advanced ovarian cancer.
Baekelandt M; Holm R; Nesland JM; Tropé CG; Kristensen GB
J Clin Oncol; 2000 Nov; 18(22):3775-81. PubMed ID: 11078490
[TBL] [Abstract][Full Text] [Related]
11. Serum vascular endothelial growth factor (VEGF) and bcl-2 levels in advanced stage non-small cell lung cancer.
Tas F; Duranyildiz D; Oguz H; Camlica H; Yasasever V; Topuz E
Cancer Invest; 2006 Oct; 24(6):576-80. PubMed ID: 16982461
[TBL] [Abstract][Full Text] [Related]
12. Urinary levels of Bcl-2 are elevated in ovarian cancer patients.
Anderson NS; Bermudez Y; Badgwell D; Chen R; Nicosia SV; Bast RC; Kruk PA
Gynecol Oncol; 2009 Jan; 112(1):60-7. PubMed ID: 19007973
[TBL] [Abstract][Full Text] [Related]
13. Level and evaluation of tumor marker CA-125 in ovarian cancer patients in Khyber Pakhtunkhwa, Pakistan.
Ahmad B; Nawaz S; Ali S; Bashir S; Mahmood N; Gul B
Asian Pac J Cancer Prev; 2015; 16(1):185-9. PubMed ID: 25640349
[TBL] [Abstract][Full Text] [Related]
14. Serum bcl-2 and survivin levels in melanoma.
Tas F; Duranyildiz D; Argon A; Oguz H; Camlica H; Yasasever V; Topuz E
Melanoma Res; 2004 Dec; 14(6):543-6. PubMed ID: 15577328
[TBL] [Abstract][Full Text] [Related]
15. Estimation of the usefulness of neoplastic markers TPS and CA 125 in diagnosis and monitoring of ovarian cancer.
Zygmunt A; Madry R; Markowska J; Fischer Z
Eur J Gynaecol Oncol; 1999; 20(4):298-301. PubMed ID: 10475127
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic value of serum CA(125) level change during chemotherapy post-surgery in patients with advanced epithelial ovarian carcinoma].
Lan CY; Huang H; Liu JH
Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):732-6. PubMed ID: 19087537
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of pretreatment CA 125 in patients with advanced ovarian carcinoma: a Gynecologic Oncology Group study.
Zorn KK; Tian C; McGuire WP; Hoskins WJ; Markman M; Muggia FM; Rose PG; Ozols RF; Spriggs D; Armstrong DK
Cancer; 2009 Mar; 115(5):1028-35. PubMed ID: 19156927
[TBL] [Abstract][Full Text] [Related]
18. Preoperative value of CA 125 as a reflection of tumor grade in epithelial ovarian cancer.
But I; Gorisek B
Gynecol Oncol; 1996 Nov; 63(2):166-72. PubMed ID: 8910622
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of pre-operative serum tetranectin, CA-125 and a combined index in women with primary ovarian cancer.
Høgdall CK; Nørgaard-Pedersen B; Mogensen O
Anticancer Res; 2002; 22(3):1765-8. PubMed ID: 12168866
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of serum kallikrein-related peptidases 6 and 10 versus CA125 in ovarian cancer.
El Sherbini MA; Sallam MM; Shaban EA; El-Shalakany AH
Int J Gynecol Cancer; 2011 May; 21(4):625-32. PubMed ID: 21412167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]